S 1196 New York Senate · 2023 Regular Session

Requires health insurance policies and medicaid to cover biomarker testing for certain purposes

Summary
Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.
Bill status signed all 5 stages cleared
Introduction
Jan 2023
Committee Review
Jun 2023
Senate Passage
Jun 2023
Assembly Passage
Jun 2023
Signed into Law
Dec 2023
Introduced Jan 10, 2023 Signed Dec 22, 2023
Floor votes · Senate Jun 5, 2023 · Assembly Jun 9, 2023

How they voted

61–0
Passed · 2 other
Total votes 63
Jun 5, 2023
D Democratic42
40 Yea 2
95% Yea
R Republican21
21 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
17
Key actions
6
Committee
4
Amendments
2
Dec 22, 2023
Signed into law
SIGNED CHAP.754
upper
Jun 9, 2023
Assembly · Passed
Assembly Vote: pass (142-2-5)
assembly
Jun 8, 2023
Lower · Passed
PASSED ASSEMBLY
lower
Jun 5, 2023
Committee
REFERRED TO WAYS AND MEANS
lower
Jun 5, 2023
Upper · Passed
PASSED SENATE
upper
Jun 5, 2023
Committee
COMMITTEE DISCHARGED AND COMMITTED TO RULES
upper
Jun 1, 2023
Upper · Passed
PRINT NUMBER 1196A
upper
Jun 1, 2023
Upper · Passed
AMEND AND RECOMMIT TO FINANCE
upper
May 22, 2023
Committee
REPORTED AND COMMITTED TO FINANCE
upper
Jan 10, 2023
Committee
REFERRED TO INSURANCE
upper
1 primary · 33 co-sponsors

Sponsors